A contest to create artwork for the cover of the 2024 PASPCR conference flyer
The PASPCR Diversity, Equity, and Inclusion (DEI) Committee recently ran a contest to solicit cover art submissions for the 2024 PASPCR conference flyer. The Meetings and the DEI Committees both participated in selecting the artwork to be used in the flyer. The identities of the artists were not known to the judges. The first place winning artwork will be shown on the front cover of the conference flyer and a collage of the second and third place winners will be shown on the back cover.
Congratulations to the winners and thank you to all of the participants!
Abigail is a rising 8th grader. She loves song writing, singing, basketball, and softball. She enjoys all types of art. When she grows up, she wants to be a doctor or a professional singer.
Second place (a tie)
by Estefania Vázquez
Estefania Vázquez is a PhD candidate working at the Cancer Genetics and Bioinformatics Lab at LIIGH UNAM (Autonomous University of Mexico). She is working on the bioinformatic analysis of tumors from Mexican patients with acral lentiginous melanoma (ALM), in an effort to understand the biology of these aggressive tumors associated with a poor prognosis and recurrence. She seeks to better understand the components of the tumor immune microenvironment in ALM, and she hopes patients in Latin America will benefit from better tumor stratification and treatment alternatives.
by John D’Orazio
John D’Orazio is a Professor of Pediatrics and Chief of Pediatric Hematology-Oncology at the University of Kentucky. His research focuses on inherited cancer syndromes that affect children and young adults. His laboratory focuses on the melanocortin 1 receptor (MC1R) which is a major determinant of lifetime melanoma risk. By understanding the molecular events that cause cancer, John and his team strive to develop effective anti-melanoma therapies.
by Carlos Cabrera
Carlos Cabrera works in a scientific research center in Mexico (CICESE). Last year, he completed his PhD in computer sciences with a specialty in Artificial Intelligence and computer vision, applying these technologies in bioimaging of prostate cancer (bright field microscopy), drug-loaded nanogels (fluorescence microscopy) and TEM heterogeneous nanostructured particles. He has started his own company, which uses AI in projects on life, health, and cancer.